Providing individualized healthcare solutions, Tempus AI is leveraging the power of AI to offer leading diagnostics and treatment options. TD Cowen’s dismissal of the critical report from Spruce Point Capital Management was merely one factor contributing to Tempus AI stock’s rise in June. Prospective investors who are willing to endure some volatility may still benefit from a position in Tempus AI.